Brief: Cue Health Receives Singapore HSA Authorization For Its Molecular Covid-19 Test For Self-Testing
Dec 1 (Reuters) - Cue Health Inc HLTH.O :
* CUE HEALTH RECEIVES SINGAPORE HSA AUTHORIZATION FOR ITS
MOLECULAR COVID-19 TEST FOR SELF-TESTING
* CUE HEALTH - CUE HEALTH HAS PARTNERED WITH OMNICELL PTE
LTD TO
IMMEDIATELY BEGIN SUPPLYING CUE COVID-19 TEST IN SINGAPORE
Source text for Eikon: ID:nPn5jL8fma
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022